Published in Osteoporos Int on September 08, 2004
Strength Training in Hypoxia to Improve Bone and Cardiovascular Health of Elderly | NCT04281264
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int (2006) 11.05
Critical review: vegetables and fruit in the prevention of chronic diseases. Eur J Nutr (2012) 3.48
The incidence and residual lifetime risk of osteoporosis-related fractures in Korea. J Bone Miner Metab (2011) 1.88
Hip fractures and heart failure: findings from the Cardiovascular Health Study. Eur Heart J (2009) 1.72
Incidence of second hip fracture and compliant use of bisphosphonate. Osteoporos Int (2012) 1.64
WNT16 influences bone mineral density, cortical bone thickness, bone strength, and osteoporotic fracture risk. PLoS Genet (2012) 1.55
Recent trends in the incidence and lifetime risk of hip fracture in Tottori, Japan. Osteoporos Int (2008) 1.55
Digital X-ray radiogrammetry of hand or wrist radiographs can predict hip fracture risk--a study in 5,420 women and 2,837 men. Eur Radiol (2012) 1.49
Bisphosphonate use is associated with reduced risk of myocardial infarction in patients with rheumatoid arthritis. J Bone Miner Res (2013) 1.44
Calcium vitamin D3 supplementation in clinical practice: side effect and satisfaction. J Diabetes Metab Disord (2016) 1.39
Trend in hip fracture epidemiology over a 14-year period in a Spanish population. Osteoporos Int (2005) 1.38
Estimated prevalence and patterns of presumed osteoporosis among older Americans based on Medicare data. Osteoporos Int (2009) 1.34
Epidemiology of distal forearm fractures in Oslo, Norway. Osteoporos Int (2008) 1.32
Epidemiology of hip fractures in Austria: evidence for a change in the secular trend. Osteoporos Int (2010) 1.29
The effects of exercise and physical activity participation on bone mass and geometry in postmenopausal women: a systematic review of pQCT studies. Osteoporos Int (2009) 1.24
Bisphosphonates in the management of postmenopausal osteoporosis--optimizing efficacy in clinical practice. Clin Interv Aging (2008) 1.22
Albuminuria is Not an Appropriate Therapeutic Target in Patients with CKD: The Con View. Clin J Am Soc Nephrol (2015) 1.18
Reduced morbidity for elderly patients with a hip fracture after implementation of a perioperative evidence-based clinical pathway. Qual Saf Health Care (2006) 1.17
Pathway-based genome-wide association analysis identified the importance of regulation-of-autophagy pathway for ultradistal radius BMD. J Bone Miner Res (2010) 1.15
QCT-based finite element models predict human vertebral strength in vitro significantly better than simulated DEXA. Osteoporos Int (2011) 1.11
The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)--quality of life during the first 4 months after fracture. Osteoporos Int (2013) 1.08
Hip fracture risk in relation to vitamin D supplementation and serum 25-hydroxyvitamin D levels: a systematic review and meta-analysis of randomised controlled trials and observational studies. BMC Public Health (2010) 1.07
Significance of sagittal reformations in routine thoracic and abdominal multislice CT studies for detecting osteoporotic fractures and other spine abnormalities. Eur Radiol (2008) 1.05
Age- and gender-dependent changes in three-dimensional microstructure of cortical and trabecular bone at the human femoral neck. Osteoporos Int (2009) 1.02
The effectiveness of a geriatric hip fracture clinical pathway in reducing hospital and rehabilitation length of stay and improving short-term mortality rates. Geriatr Orthop Surg Rehabil (2013) 1.02
A systematic review of the outcomes of osteoporotic fracture patients after hospital discharge: morbidity, subsequent fractures, and mortality. Ther Clin Risk Manag (2014) 1.02
Epidemiology of osteoporosis related fractures in Hungary from the nationwide health insurance database, 1999-2003. Osteoporos Int (2007) 1.01
Osteoporosis prevention, screening, and treatment: a review. J Womens Health (Larchmt) (2014) 1.01
Potential impact of benzodiazepine use on the rate of hip fractures in five large European countries and the United States. Calcif Tissue Int (2012) 1.00
Exercise effects on bone mineral density in older adults: a meta-analysis of randomized controlled trials. Age (Dordr) (2011) 0.99
Assessment of trabecular bone structure using MDCT: comparison of 64- and 320-slice CT using HR-pQCT as the reference standard. Eur Radiol (2009) 0.99
High weight or body mass index increase the risk of vertebral fractures in postmenopausal osteoporotic women. J Bone Miner Metab (2009) 0.99
New advances in musculoskeletal pain. Brain Res Rev (2008) 0.99
Vertebral fracture assessment: impact of instrument and reader. Osteoporos Int (2009) 0.98
Hip fracture types in men and women change differently with age. BMC Geriatr (2010) 0.98
Adherence, preference, and satisfaction of postmenopausal women taking denosumab or alendronate. Osteoporos Int (2010) 0.98
Single-nucleotide polymorphisms in the P2X7 receptor gene are associated with post-menopausal bone loss and vertebral fractures. Eur J Hum Genet (2012) 0.98
Hip fractures in Norway 1999-2008: time trends in total incidence and second hip fracture rates: a NOREPOS study. Eur J Epidemiol (2012) 0.97
Geriatric hip fracture clinical pathway: the Hong Kong experience. Osteoporos Int (2010) 0.97
Estimation of direct unit costs associated with non-vertebral osteoporotic fractures in five European countries. Rheumatol Int (2006) 0.96
Clinical risk factors for osteoporotic fractures in Brazilian women and men: the Brazilian Osteoporosis Study (BRAZOS). Osteoporos Int (2008) 0.95
Geriatric syndromes and incident disability in older women: results from the women's health initiative observational study. J Am Geriatr Soc (2013) 0.95
The gender- and age-specific 10-year and lifetime absolute fracture risk in Tromsø, Norway. Eur J Epidemiol (2009) 0.95
Prevalence of vertebral fractures in women and men in the population-based Tromsø Study. BMC Musculoskelet Disord (2012) 0.94
Mapping the prescriptiome to fractures in men--a national analysis of prescription history and fracture risk. Osteoporos Int (2008) 0.93
Outcome in geriatric fracture patients and how it can be improved. Osteoporos Int (2010) 0.92
Burden of hip fracture on inpatient care: a before and after population-based study. Osteoporos Int (2009) 0.92
Mortality within 1 year after hip fracture surgical repair in the elderly according to postoperative period: a probabilistic record linkage study in Brazil. Osteoporos Int (2006) 0.91
Hospitalisations for fracture and associated costs between 2000 and 2009 in Ireland: a trend analysis. Osteoporos Int (2012) 0.90
Undertreatment of osteoporosis in the oldest old? A nationwide study of over 700,000 older people. Arch Osteoporos (2009) 0.90
Economic burden of osteoporotic fractures in Austria. Health Econ Rev (2012) 0.90
The impact of prefracture and hip fracture characteristics on mortality in older persons in Brazil. Clin Orthop Relat Res (2009) 0.90
Effect of low-power gallium-aluminum-arsenium laser therapy (830 nm) in combination with bisphosphonate treatment on osteopenic bone structure: an experimental animal study. Lasers Med Sci (2008) 0.89
Delay from fracture to hospital admission: a new risk factor for hip fracture mortality? Osteoporos Int (2012) 0.89
Young patients with hip fracture: a population-based study of bone mass and risk factors for osteoporosis. Osteoporos Int (2006) 0.89
Osteoporotic Fracture: 2015 Position Statement of the Korean Society for Bone and Mineral Research. J Bone Metab (2015) 0.89
Epidemiology of osteoporosis and osteoporotic fractures in South Korea. Endocrinol Metab (Seoul) (2013) 0.89
Leisure time physical activity and risk of non-vertebral fracture in men and women aged 55 years and older: the Tromsø Study. Eur J Epidemiol (2012) 0.89
Percentage of the population at high risk of osteoporotic fracture in South Korea: analysis of the 2010 Fifth Korean National Health and Nutrition Examination survey data. Osteoporos Int (2013) 0.89
Undertreatment of osteoporosis in persons with dementia? A population-based study. Osteoporos Int (2011) 0.88
Determinants of the mechanical behavior of human lumbar vertebrae after simulated mild fracture. J Bone Miner Res (2011) 0.87
Do estrogen and alendronate improve metaphyseal fracture healing when applied as osteoporosis prophylaxis? Calcif Tissue Int (2009) 0.87
Projection of osteoporosis-related fractures and costs in China: 2010-2050. Osteoporos Int (2015) 0.87
Management of osteoporosis and associated quality of life in post menopausal women. BMC Musculoskelet Disord (2011) 0.87
Once-yearly zoledronic acid in hip fracture prevention. Clin Interv Aging (2009) 0.86
The development of a clinical decision making algorithm for detection of osteoporotic vertebral compression fracture or wedge deformity. J Man Manip Ther (2010) 0.86
The association between non-melanoma skin cancer and osteoporotic fractures--a population-based record linkage study. Osteoporos Int (2007) 0.86
Epidemiology of proximal humeral fractures in Austria between 1989 and 2008. Osteoporos Int (2013) 0.86
Association between circulating osteoprogenitor cell numbers and bone mineral density in postmenopausal osteoporosis. Osteoporos Int (2009) 0.86
Burden of high fracture probability worldwide: secular increases 2010-2040. Osteoporos Int (2015) 0.85
Osteoporotic hip fractures in non-elderly patients: relevance of associated co-morbidities. Rheumatol Int (2011) 0.85
New dual-energy X-ray absorptiometry equipment in the assessment of vertebral fractures: technical limits and software accuracy. Skeletal Radiol (2011) 0.84
Surgical approach to bone healing in osteoporosis. Clin Cases Miner Bone Metab (2009) 0.84
Is a lower dose of vitamin D supplementation enough to increase 25(OH)D status in a sunny country? Eur J Nutr (2009) 0.84
Estimated GFR and fracture risk: a population-based study. Clin J Am Soc Nephrol (2013) 0.84
Expected lifetime numbers and costs of fractures in postmenopausal women with and without osteoporosis in Germany: a discrete event simulation model. BMC Health Serv Res (2014) 0.84
Incidence of fractures requiring inpatient care. Acta Orthop (2014) 0.83
Ankle fractures have features of an osteoporotic fracture. Osteoporos Int (2013) 0.83
Self-perceived facture risk: factors underlying women's perception of risk for osteoporotic fractures: the Risk-Stratified Osteoporosis Strategy Evaluation study (ROSE). Osteoporos Int (2014) 0.83
Dystrophin and utrophin "double knockout" dystrophic mice exhibit a spectrum of degenerative musculoskeletal abnormalities. J Orthop Res (2012) 0.83
Risk factors affecting progressive collapse of acute osteoporotic spinal fractures. Osteoporos Int (2012) 0.83
Predictors of new and severe vertebral fractures: results from the HORIZON Pivotal Fracture Trial. Osteoporos Int (2011) 0.83
Cortical and trabecular bone structure analysis at the distal radius-prediction of biomechanical strength by DXA and MRI. J Bone Miner Metab (2012) 0.83
Association between inflammatory biomarkers and bone mineral density in a community-based cohort of men and women. Arthritis Care Res (Hoboken) (2014) 0.82
Biomarkers of bone turnover in diagnosis and therapy of osteoporosis: a consensus advice from an Austrian working group. Wien Med Wochenschr (2012) 0.82
Influence of creatine supplementation on bone quality in the ovariectomized rat model: an FT-Raman spectroscopy study. Lasers Med Sci (2011) 0.82
The mode of school transportation in pre-pubertal children does not influence the accrual of bone mineral or the gain in bone size--two year prospective data from the paediatric osteoporosis preventive (POP) study. BMC Musculoskelet Disord (2010) 0.81
Safety and effectiveness of daily teriparatide in a prospective observational study in patients with osteoporosis at high risk of fracture in Japan: final report. Clin Interv Aging (2016) 0.81
Simulation-based cost-utility analysis of population screening-based alendronate use in Switzerland. Osteoporos Int (2007) 0.81
Comparison of interactive voice response, patient mailing, and mailed registry to encourage screening for osteoporosis: a randomized controlled trial. Osteoporos Int (2014) 0.81
The ovariectomized rat as a model for studying alveolar bone loss in postmenopausal women. Biomed Res Int (2015) 0.80
Fracture incidence in a large cohort of men age 30 years and older with osteoporosis. Osteoporos Int (2015) 0.80
Trends in hip fracture incidence in young and older adults. Am J Public Health (2007) 0.80
Greater intake of fruit and vegetables is associated with a lower risk of osteoporotic hip fractures in elderly Chinese: a 1:1 matched case-control study. Osteoporos Int (2013) 0.80
Association between passive smoking in adulthood and phalangeal bone mineral density: results from the KRAM study--the Danish Health Examination Survey 2007-2008. Osteoporos Int (2010) 0.80
Childhood obesity, bone development, and cardiometabolic risk factors. Mol Cell Endocrinol (2015) 0.79
Does osteoporosis increase complication risk in surgical fracture treatment? A protocol combining new endpoints for two prospective multicentre open cohort studies. BMC Musculoskelet Disord (2010) 0.79
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser (1994) 17.37
Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med (1992) 12.89
Hip fractures in the elderly: a world-wide projection. Osteoporos Int (1992) 9.08
Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res (2000) 7.29
World-wide projections for hip fracture. Osteoporos Int (1997) 6.83
Epidemiology of fractures in England and Wales. Bone (2001) 5.76
Perspective. How many women have osteoporosis? J Bone Miner Res (1992) 4.99
Mortality after osteoporotic fractures. Osteoporos Int (2003) 3.68
Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res (2002) 3.16
International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res (2002) 3.14
The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med (1998) 3.13
Long-term risk of osteoporotic fracture in Malmö. Osteoporos Int (2000) 2.99
The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int (2001) 2.81
Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group. J Am Geriatr Soc (2000) 2.80
The components of excess mortality after hip fracture. Bone (2003) 2.63
Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis The Study of Osteoporotic Fractures Research Group. J Bone Miner Res (1996) 2.46
Fracture risk following an osteoporotic fracture. Osteoporos Int (2003) 2.21
The socioeconomic burden of fractures: today and in the 21st century. Am J Med (1997) 2.06
The relationship of health-related quality of life to prevalent and incident vertebral fractures in postmenopausal women with osteoporosis: results from the Multiple Outcomes of Raloxifene Evaluation Study. Arthritis Rheum (2001) 2.00
Consensus development conference: prophylaxis and treatment of osteoporosis. Am J Med (1991) 2.00
Non-trauma mortality in elderly women with low bone mineral density. Study of Osteoporotic Fractures Research Group. Lancet (1991) 1.78
Mortality associated with vertebral deformity in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (1998) 1.76
Excess mortality after hospitalisation for vertebral fracture. Osteoporos Int (2003) 1.76
The risk and burden of vertebral fractures in Sweden. Osteoporos Int (2003) 1.74
Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis Study. Osteoporos Int (2003) 1.74
Consequences of a hip fracture: a prospective study over 1 year. Osteoporos Int (1993) 1.53
Bone mineral density is a predictor of survival. Calcif Tissue Int (1998) 1.32
Incremental cost of medical care after hip fracture and first vertebral fracture: the Rotterdam study. Osteoporos Int (1999) 0.99
Lifetime and five-year age-specific risks of first and subsequent osteoporotic fractures in postmenopausal women. Osteoporos Int (2001) 0.99
The incidence of thoracic vertebral fractures in a Japanese population, Hiroshima and Nagasaki, 1958-86. J Clin Epidemiol (1991) 0.83
Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]. Breast Cancer Res (2006) 1.71
Idiopathic hyperphosphatasia and TNFRSF11B mutations: relationships between phenotype and genotype. J Bone Miner Res (2003) 1.17
Confused thinking about discrepancies in predicted fracture risk in older people. BMJ (2013) 1.08
Extended safety profile of oral clodronate after long-term use in primary breast cancer patients. Drug Saf (2003) 0.88
Can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on epidemiology and phenotype of osteoarthritis. Drugs Aging (2015) 0.84
Gaucher disease and bone manifestations. Calcif Tissue Int (2014) 0.83
Effect of oral clodronate on bone mass, bone turnover and subsequent metastases in women with primary breast cancer. Eur J Cancer (2009) 0.80
Reassessment of the cost-effectiveness of hormone replacement therapy in Sweden: results based on the Women's Health Initiative randomized controlled trial. Int J Technol Assess Health Care (2005) 0.79
Osteoporosis management by geriatricians in the UK. Age Ageing (2003) 0.78
Comments on the discordant recommendations for the use of symptomatic slow-acting drugs in knee osteoarthritis. Curr Med Res Opin (2015) 0.77
Evaluation of the FRAX model for hip fracture predictions in the population-based Kuopio Osteoporosis Risk Factor and Prevention Study (OSTPRE). Calcif Tissue Int (2014) 0.75